{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:44:48Z","timestamp":1775119488300,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Macao Polytechnic University","award":["RP\/FCA-01\/2022"],"award-info":[{"award-number":["RP\/FCA-01\/2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10822-023-00530-4","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:02:07Z","timestamp":1693292527000},"page":"695-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Discovery of novel and potent InhA direct inhibitors by ensemble docking-based virtual screening and biological assays"],"prefix":"10.1007","volume":"37","author":[{"given":"Qianqian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianting","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongchang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fansen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry H. Y.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"issue":"1","key":"530_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40249-021-00803-w","volume":"10","author":"ZJ Ou","year":"2021","unstructured":"Ou ZJ et al (2021) Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study. Infect Dis Poverty 10(1):24","journal-title":"Infect Dis Poverty"},{"issue":"3","key":"530_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1358\/dot.2019.55.3.2927587","volume":"55","author":"G Kaul","year":"2019","unstructured":"Kaul G et al (2019) Management of multidrug-resistant tuberculosis in the 21st century. Drugs Today (Barc) 55(3):215\u2013224","journal-title":"Drugs Today (Barc)"},{"key":"530_CR3","unstructured":"World Health Organization. Global tuberculosis report 2021"},{"issue":"1","key":"530_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1513\/AnnalsATS.201902-185CME","volume":"17","author":"JW Wilson","year":"2020","unstructured":"Wilson JW, Nilsen DM, Marks SM (2020) Multidrug-resistant tuberculosis in patients with human immunodeficiency virus. Management considerations within high-resourced settings. Ann Am Thorac Soc 17(1):16\u201323","journal-title":"Ann Am Thorac Soc"},{"key":"530_CR5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2217\/fmb-2017-0135","volume":"13","author":"P Singh","year":"2018","unstructured":"Singh P et al (2018) Cell envelope lipids in the pathophysiology of Mycobacterium tuberculosis. Future Microbiol 13:689\u2013710","journal-title":"Future Microbiol"},{"issue":"6","key":"530_CR6","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/j.1365-2958.2007.05761.x","volume":"64","author":"A Bhatt","year":"2007","unstructured":"Bhatt A, Besra MV, Jacobs GS, Kremer WR Jr (2007) The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. Mol Microbiol 64(6):1442\u20131454","journal-title":"Mol Microbiol"},{"issue":"2","key":"530_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/1574-6968.12597","volume":"360","author":"X Duan","year":"2014","unstructured":"Duan X, Xiang X, Xie J (2014) Crucial components of mycobacterium type II fatty acid biosynthesis (Fas-II) and their inhibitors. FEMS Microbiol Lett 360(2):87\u201399","journal-title":"FEMS Microbiol Lett"},{"issue":"16","key":"530_CR8","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1128\/AEM.00655-08","volume":"74","author":"A Gurvitz","year":"2008","unstructured":"Gurvitz A, Hiltunen JK, Kastaniotis AJ (2008) Function of heterologous Mycobacterium tuberculosis InhA, a type 2 fatty acid synthase enzyme involved in extending C20 fatty acids to C60-to-C90 mycolic acids, during de novo lipoic acid synthesis in Saccharomyces cerevisiae. Appl Environ Microbiol 74(16):5078\u20135085","journal-title":"Appl Environ Microbiol"},{"issue":"Pt 2","key":"530_CR9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1099\/00221287-146-2-289","volume":"146","author":"H Marrakchi","year":"2000","unstructured":"Marrakchi H, Lan\u00e9elle G, Qu\u00e9mard AK (2000) InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 146(Pt 2):289\u2013296","journal-title":"Microbiology"},{"issue":"5144","key":"530_CR10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","volume":"263","author":"A Banerjee","year":"1994","unstructured":"Banerjee A et al (1994) inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263(5144):227\u2013230","journal-title":"Science"},{"issue":"9","key":"530_CR11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nm1466","volume":"12","author":"C Vilcheze","year":"2006","unstructured":"Vilcheze C et al (2006) Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med 12(9):1027\u20131029","journal-title":"Nat Med"},{"issue":"4","key":"530_CR12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jmgm.2008.09.006","volume":"27","author":"JL Stigliani","year":"2008","unstructured":"Stigliani JL et al (2008) Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach. J Mol Graph Model 27(4):536\u2013545","journal-title":"J Mol Graph Model"},{"issue":"10","key":"530_CR13","first-page":"920","volume":"6","author":"S Ahmad","year":"2002","unstructured":"Ahmad S et al (2002) Prevalence of S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Dubai and Beirut. Int J Tuberc Lung Dis 6(10):920\u2013926","journal-title":"Int J Tuberc Lung Dis"},{"key":"530_CR14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.addr.2016.04.026","volume":"102","author":"DT Hoagland","year":"2016","unstructured":"Hoagland DT et al (2016) New agents for the treatment of drug-resistant Mycobacterium tuberculosis. Adv Drug Deliv Rev 102:55\u201372","journal-title":"Adv Drug Deliv Rev"},{"key":"530_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ebiom.2016.05.006","volume":"8","author":"M Mart\u00ednez-Hoyos","year":"2016","unstructured":"Mart\u00ednez-Hoyos M et al (2016) Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor. EBioMedicine 8:291\u2013301","journal-title":"EBioMedicine"},{"key":"530_CR16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2018.01.047","volume":"146","author":"A Chollet","year":"2018","unstructured":"Chollet A et al (2018) An overview on crystal structures of InhA protein: Apo-form, in complex with its natural ligands and inhibitors. Eur J Med Chem 146:318\u2013343","journal-title":"Eur J Med Chem"},{"issue":"23","key":"530_CR17","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1016\/j.bmc.2006.07.034","volume":"14","author":"M Chhibber","year":"2006","unstructured":"Chhibber M et al (2006) Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli. Bioorg Med Chem 14(23):8086\u20138098","journal-title":"Bioorg Med Chem"},{"key":"530_CR18","doi-asserted-by":"crossref","unstructured":"Chetty S et al (2021) New InhA inhibitors based on expanded Triclosan and Di-Triclosan Analogues to develop a New Treatment for Tuberculosis. Pharmaceuticals (Basel), 14(4)","DOI":"10.3390\/ph14040361"},{"issue":"2","key":"530_CR19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cmdc.200800261","volume":"4","author":"JS Freundlich","year":"2009","unstructured":"Freundlich JS et al (2009) Triclosan derivatives: towards potent inhibitors of drug-sensitive and drug-resistant Mycobacterium tuberculosis. ChemMedChem 4(2):241\u2013248","journal-title":"ChemMedChem"},{"issue":"21","key":"530_CR20","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1021\/jm060715y","volume":"49","author":"X He","year":"2006","unstructured":"He X et al (2006) Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. J Med Chem 49(21):6308\u20136323","journal-title":"J Med Chem"},{"issue":"21","key":"530_CR21","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.bmc.2007.08.013","volume":"15","author":"X He","year":"2007","unstructured":"He X, Alian A, Ortiz de PR, Montellano (2007) Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. Bioorg Med Chem 15(21):6649\u20136658","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"530_CR22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/cmdc.201600020","volume":"11","author":"A Guardia","year":"2016","unstructured":"Guardia A et al (2016) Benzyl-4-((heteroaryl)methyl)benzamides: a New Class of Direct NADH-Dependent 2-trans enoyl-acyl carrier protein reductase (InhA) inhibitors with antitubercular activity. ChemMedChem 11(7):687\u2013701","journal-title":"ChemMedChem"},{"issue":"23","key":"530_CR23","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M211968200","volume":"278","author":"MR Kuo","year":"2003","unstructured":"Kuo MR et al (2003) Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data. J Biol Chem 278(23):20851\u201320859","journal-title":"J Biol Chem"},{"issue":"4","key":"530_CR24","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/jm401326j","volume":"57","author":"L Encinas","year":"2014","unstructured":"Encinas L et al (2014) Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of Mycobacterium tuberculosis InhA. J Med Chem 57(4):1276\u20131288","journal-title":"J Med Chem"},{"issue":"49","key":"530_CR25","doi-asserted-by":"crossref","first-page":"E7880","DOI":"10.1073\/pnas.1610978113","volume":"113","author":"HH Soutter","year":"2016","unstructured":"Soutter HH et al (2016) Discovery of cofactor-specific, bactericidal Mycobacterium tuberculosis InhA inhibitors using DNA-encoded library technology. Proc Natl Acad Sci U S A 113(49):E7880\u2013E7889","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"530_CR26","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1021\/acs.jmedchem.0c00007","volume":"63","author":"M Sabbah","year":"2020","unstructured":"Sabbah M et al (2020) Fragment-based design of Mycobacterium tuberculosis InhA inhibitors. J Med Chem 63(9):4749\u20134761","journal-title":"J Med Chem"},{"key":"530_CR27","doi-asserted-by":"crossref","unstructured":"Singh K et al (2022) Identification of novel inhibitor of Enoyl-Acyl carrier protein reductase (InhA) enzyme in Mycobacterium tuberculosis from Plant-Derived Metabolites: an in Silico Study. Antibiot (Basel), 11(8)","DOI":"10.3390\/antibiotics11081038"},{"issue":"1","key":"530_CR28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/acs.jcim.9b00918","volume":"60","author":"P Kamsri","year":"2020","unstructured":"Kamsri P et al (2020) Discovery of New and potent InhA inhibitors as Antituberculosis Agents: structure-based virtual screening validated by biological assays and X-ray crystallography. J Chem Inf Model 60(1):226\u2013234","journal-title":"J Chem Inf Model"},{"issue":"11","key":"530_CR29","doi-asserted-by":"crossref","first-page":"e0239354","DOI":"10.1371\/journal.pone.0239354","volume":"15","author":"L Flint","year":"2020","unstructured":"Flint L, Korkegian A, Parish T (2020) InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis. PLoS ONE 15(11):e0239354","journal-title":"PLoS ONE"},{"issue":"19","key":"530_CR30","doi-asserted-by":"crossref","first-page":"14330","DOI":"10.1074\/jbc.M109.090373","volume":"285","author":"SR Luckner","year":"2010","unstructured":"Luckner SR et al (2010) A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis. J Biol Chem 285(19):14330\u201314337","journal-title":"J Biol Chem"},{"issue":"4","key":"530_CR31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/14756366.2014.959512","volume":"30","author":"O Holas","year":"2015","unstructured":"Holas O, Ondrejcek P, Dolezal M (2015) Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade. J Enzyme Inhib Med Chem 30(4):629\u2013648","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"6","key":"530_CR32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/138620711795767866","volume":"14","author":"F L\u00f3pez-Vallejo","year":"2011","unstructured":"L\u00f3pez-Vallejo F et al (2011) Integrating virtual screening and combinatorial chemistry for accelerated drug discovery. Comb Chem High Throughput Screen 14(6):475\u2013487","journal-title":"Comb Chem High Throughput Screen"},{"issue":"7","key":"530_CR33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/17460441.2019.1604677","volume":"14","author":"O Slater","year":"2019","unstructured":"Slater O, Kontoyianni M (2019) The compromise of virtual screening and its impact on drug discovery. Expert Opin Drug Discov 14(7):619\u2013637","journal-title":"Expert Opin Drug Discov"},{"issue":"19","key":"530_CR34","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2174\/1568026619666190816101948","volume":"19","author":"SFL da Silva Rocha","year":"2019","unstructured":"da Silva Rocha SFL et al (2019) Virtual screening techniques in Drug Discovery: review and recent applications. Curr Top Med Chem 19(19):1751\u20131767","journal-title":"Curr Top Med Chem"},{"issue":"9","key":"530_CR35","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1021\/acs.jcim.0c00115","volume":"60","author":"AE Cleves","year":"2020","unstructured":"Cleves AE, Jain AN (2020) Structure- and ligand-based virtual screening on DUD-E(+): performance dependence on Approximations to the binding Pocket. J Chem Inf Model 60(9):4296\u20134310","journal-title":"J Chem Inf Model"},{"issue":"2","key":"530_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10408347.2014.881250","volume":"45","author":"A Olaru","year":"2015","unstructured":"Olaru A et al (2015) Surface plasmon resonance (SPR) biosensors in pharmaceutical analysis. Crit Rev Anal Chem 45(2):97\u2013105","journal-title":"Crit Rev Anal Chem"},{"issue":"14","key":"530_CR37","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM et al (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55(14):6582\u20136594","journal-title":"J Med Chem"},{"issue":"23","key":"530_CR38","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1021\/jm0608356","volume":"49","author":"N Huang","year":"2006","unstructured":"Huang N, Shoichet BK, Irwin JJ (2006) Benchmarking sets for molecular docking. J Med Chem 49(23):6789\u20136801","journal-title":"J Med Chem"},{"key":"530_CR39","volume-title":"AMBER 2020","author":"DAB Case","year":"2020","unstructured":"Case DAB, Ben-Shalom K, Brozell IY, Cerutti SR, Cheatham DS, Cruzeiro TEIII, Darden VWD, Duke TA, Giambasu RE (2020) G.; et al., AMBER 2020. University of California, San Francisco, CA, USA"},{"key":"530_CR40","doi-asserted-by":"crossref","unstructured":"Genheden S, Ryde U (2012) Comparison of end-point continuum\u2010solvation methods for the calculation of protein\u2013ligand binding free energies Proteins: Structure, Function, and Bioinformatics, 80(5): p.\u00a01326\u20131342","DOI":"10.1002\/prot.24029"},{"issue":"16","key":"530_CR41","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E et al (2019) End-point binding Free Energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in Drug Design. Chem Rev 119(16):9478\u20139508","journal-title":"Chem Rev"},{"issue":"5","key":"530_CR42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1021\/acschemneuro.1c00726","volume":"13","author":"S Tan","year":"2022","unstructured":"Tan S et al (2022) Molecular modeling study on the Interaction mechanism between the LRRK2 G2019S mutant and type I inhibitors by integrating Molecular Dynamics Simulation, binding Free Energy Calculations, and Pharmacophore modeling. ACS Chem Neurosci 13(5):599\u2013612","journal-title":"ACS Chem Neurosci"},{"issue":"17","key":"530_CR43","doi-asserted-by":"crossref","first-page":"10102","DOI":"10.3390\/ijms231710102","volume":"23","author":"Q Zhang","year":"2022","unstructured":"Zhang Q et al (2022) Binding thermodynamics and dissociation Kinetics Analysis uncover the key structural motifs of phenoxyphenol derivatives as the direct InhA inhibitors and the Hotspot residues of InhA. Int J Mol Sci 23(17):10102","journal-title":"Int J Mol Sci"},{"key":"530_CR44","doi-asserted-by":"crossref","first-page":"106434","DOI":"10.1016\/j.compbiomed.2022.106434","volume":"152","author":"N Phusi","year":"2023","unstructured":"Phusi N et al (2023) Structure-based drug design of novel M. tuberculosis InhA inhibitors based on fragment molecular orbital calculations. Comput Biol Med 152:106434","journal-title":"Comput Biol Med"},{"issue":"21","key":"530_CR45","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1021\/jm4012033","volume":"56","author":"PS Shirude","year":"2013","unstructured":"Shirude PS et al (2013) Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis. J Med Chem 56(21):8533\u20138542","journal-title":"J Med Chem"},{"issue":"22","key":"530_CR46","doi-asserted-by":"crossref","first-page":"15582","DOI":"10.1074\/jbc.274.22.15582","volume":"274","author":"DA Rozwarski","year":"1999","unstructured":"Rozwarski DA et al (1999) Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD + and a C16 fatty acyl substrate. J Biol Chem 274(22):15582\u201315589","journal-title":"J Biol Chem"},{"issue":"1\u20133","key":"530_CR47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA et al (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"530_CR48","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47(7):1750\u20131759","journal-title":"J Med Chem"},{"issue":"21","key":"530_CR49","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49(21):6177\u20136196","journal-title":"J Med Chem"},{"issue":"5","key":"530_CR50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10(5):449\u2013461","journal-title":"Expert Opin Drug Discov"},{"issue":"26","key":"530_CR51","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1021\/bi0008940","volume":"39","author":"SL Parikh","year":"2000","unstructured":"Parikh SL, Xiao G, Tonge PJ (2000) Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid. Biochemistry 39(26):7645\u20137650","journal-title":"Biochemistry"},{"key":"530_CR52","volume-title":"Gaussian 16","author":"MT Frisch","year":"2016","unstructured":"Frisch MT, Schlegel G, Scuseria H, Robb G, Cheeseman M, Scalmani J, Barone G, Petersson V, Nakatsuji G (2016) H., Gaussian 16. Gaussian. Inc., Wallingford, CT, USA"},{"key":"530_CR53","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002140100282","volume":"106","author":"S Kristy\u00e1n","year":"2001","unstructured":"Kristy\u00e1n S, Ruzsinszky A, Csonka GI (2001) Accurate thermochemistry from corrected hartree\u2013fock results: rapid estimation of nearly experimental quality total energy using the small 6-31G (d) basis set. Theor Chem Acc 106:319\u2013328","journal-title":"Theor Chem Acc"},{"issue":"1","key":"530_CR54","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2019","unstructured":"Tian C et al (2019) ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput 16(1):528\u2013552","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"530_CR55","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J et al (2004) Development and testing of a general amber force field. J Comput Chem 25(9):1157\u20131174","journal-title":"J Comput Chem"},{"issue":"20","key":"530_CR56","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","volume":"121","author":"DJ Price","year":"2004","unstructured":"Price DJ, Brooks CL (2004) A modified TIP3P water potential for simulation with Ewald summation. J Chem Phys 121(20):10096\u201310103","journal-title":"J Chem Phys"},{"issue":"30","key":"530_CR57","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1021\/jp8001614","volume":"112","author":"IS Joung","year":"2008","unstructured":"Joung IS, Cheatham TE (2008) Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. J Phys Chem B 112(30):9020\u20139041","journal-title":"J Phys Chem B"},{"issue":"24","key":"530_CR58","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1063\/1.1324708","volume":"113","author":"A Toukmaji","year":"2000","unstructured":"Toukmaji A et al (2000) Efficient particle-mesh Ewald based approach to fixed and induced dipolar interactions. J Chem Phys 113(24):10913\u201310927","journal-title":"J Chem Phys"},{"issue":"8","key":"530_CR59","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jcc.540130805","volume":"13","author":"S Miyamoto","year":"1992","unstructured":"Miyamoto S, Kollman PA (1992) Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13(8):952\u2013962","journal-title":"J Comput Chem"},{"issue":"14","key":"530_CR60","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1021\/j100116a025","volume":"97","author":"MK Gilson","year":"1993","unstructured":"Gilson MK et al (1993) Computation of electrostatic forces on solvated molecules using the Poisson-Boltzmann equation. J Phys Chem 97(14):3591\u20133600","journal-title":"J Phys Chem"},{"issue":"7","key":"530_CR61","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/j100058a043","volume":"98","author":"D Sitkoff","year":"1994","unstructured":"Sitkoff D, Sharp KA, Honig B (1994) Accurate calculation of hydration free energies using macroscopic solvent models. J Phys Chem 98(7):1978\u20131988","journal-title":"J Phys Chem"},{"issue":"2","key":"530_CR62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","volume":"20","author":"J Weiser","year":"1999","unstructured":"Weiser J, Shenkin PS, Still WC (1999) Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J Comput Chem 20(2):217\u2013230","journal-title":"J Comput Chem"},{"issue":"1\u20133","key":"530_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-4655(95)00041-D","volume":"91","author":"DA Pearlman","year":"1995","unstructured":"Pearlman DA et al (1995) AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput Phys Commun 91(1\u20133):1\u201341","journal-title":"Comput Phys Commun"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-023-00530-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-023-00530-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-023-00530-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:17:07Z","timestamp":1698779827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-023-00530-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["530"],"URL":"https:\/\/doi.org\/10.1007\/s10822-023-00530-4","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}